Study Conduct

Sponsors must consider the challenges as well as advantages when moving trials to emerging markets

Monday, January 10, 2011 07:00 AM

As drug sponsors increasingly look to emerging markets for greater patient access and lower trial costs, they must also consider the potential disadvantages of moving operations to a developing country when choosing the best location for a clinical trial, according to new research from Cutting Edge Information.

More... »

Report: Drug discovery industry must embrace open source innovation to speed process, boost bottom lines

Monday, January 3, 2011 07:30 AM

To meet the challenges of research and development, the pharmaceutical industry must adopt more open source innovation—a concept that has been used for nearly three decades by the information technology sector—to promote innovation in the drug discovery process and boost bottom lines, according to a new report by Frost & Sullivan.

More... »

Florida site group goes global with Panama City office

Monday, January 3, 2011 07:00 AM

Sponsors and CROs have gone international. Are sites next?

More... »

It’s holiday bonus time—or is it? Investigative sites split on ethics of bonuses

Friday, December 10, 2010 01:44 PM

For many workers, December is not just the holiday season. It’s the season of the holiday bonus.

More... »

Grassroots advocacy uses family relationships,trust to bolster patient recruitment

Monday, December 6, 2010 08:20 AM

Patient recruitment often creates an insurmountable bottleneck for trials. But could that be because many sponsors and CROs are overlooking more grassroots-style ways of carrying it out?

More... »

The CenterWatch Monthly December 2010

Monday, November 29, 2010 12:30 PM

Pessimism and instability defining the clinical research workforce

More... »

MyClin offers virtual communities for sponsors, CROs, sites to stay connected during trials

Monday, November 29, 2010 09:00 AM

At the investigator meeting prior to the start of a clinical trial, principal investigators and their staffs sit together to hear the sponsor explain the protocol and to ask questions. Everyone socializes over snacks or a meal, connecting faces to names and discussing the ins and outs of the trial.

More... »

FDA: Generic transdermal patches should be tested in divergent climates

Monday, November 22, 2010 09:06 AM

A patch that delivers medicine transdermally may act very differently on a resident of Fargo, N.D., than on someone in South Florida. Thus, the amount of medicine that enters their bloodstreams may be different. That’s the assertion of the FDA’s Office of Generic Drugs, and that’s why the regulatory body now asks that drug developers working on transdermal patches—at least in the generics realm—test their patches in multiple divergent climates.

More... »

Lack of recruitment, missed patient visits among new researchers’ common mistakes

Monday, November 22, 2010 09:01 AM

Some private-practice physicians who decide to conduct clinical trials can have trouble meeting enrollment goals because they forget to speak with their patients about study participation. Others inadvertently miss a patient visit and have to fill out numerous forms explaining why they deviated from the clinical trial protocol. 

More... »

Site Solutions survey: Lack of operating capital, cash flow plague investigative sites

Monday, November 15, 2010 09:17 AM

Sixty percent of investigative sites have less than three months of operating cash on hand in the bank, according to the 2010 Site Solutions Summit survey.

More... »